Adenosine inhibits tissue factor expression by LPS-stimulated human monocytes: Involvement of the A3 adenosine receptor

Thrombosis and Haemostasis

Volumn 88, Issue 1, 2002, Pages 123-130

  Broussas, Matthieu ^a   Cornillet Lefèbvre, Pascale ^a   Potron, Gérard ^a   Nguyên, Philippe ^a  

^a IFR53 Fac de Med et de Pharmacie   (France)

Author keywords

Adenosine; Adenosine receptor; Human monocytes; Tissue factor

Indexed keywords

2 CHLOROADENOSINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; CGS 2180; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHENYLISOPROPYLADENOSINE; PROCOAGULANT; THROMBOPLASTIN; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR;

ARTICLE; BLOOD CLOTTING; CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; DRUG SELECTIVITY; HEART PROTECTION; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; VOLUNTEER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADENOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; THROMBOPLASTIN;

EID: 0036303892     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613164     Document Type: Article

References (21)

1. Adenosine: A physiological modulator of superoxide anion generation by human neutrophils
2. 2-generation, respectively
3. Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by neutrophils at early step in signal transduction
4. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors
5. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to cardiac myocytes
6. Adenosine inhibits neutrophil degranulation in activated human whole blood
7. Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on FMLP-stimulated neutrophils
8. Differential regulatory effects of adenosine on cytokine release by activated human monocytes
9. Adenosine enhances IL-10 secretion by human monocytes
10. Adenosine regulates tissue factor expression on endothelial cells
11. Adenosine receptor subtypes: Characterization and therapeutic regulation
12. Inhibition of f-MLP triggered respiratory burst of human monocytes by adenosine: Involvement of A3 adenosine receptor
13. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide
14. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay
15. Inhibition of TNF-α expression by adenosine: A role for A3 adenosine receptor
16. Redox regulation of cellular signalling
17. Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes
18. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation
19. Oral dipyridamole increases plasma adenosine levels in human beings
20. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no reflow phenomenon
21. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction